Atlas Trials

A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma

Clinical trial NCT02753712 · COMPLETED

Trial details

NCT number
NCT02753712
Sponsor
Mundipharma Research Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2016-06-15
Primary completion
2017-08-14
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.